Здравоохранение

Последние новости из штаб-квартиры в Токио

Посмотреть все

• Апр. 5, 2022

  Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

• Мар. 22, 2022

  Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business
  Amendment in relation to a return of domestic marketing rights for a product

• Янв. 27, 2022

  Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

• Сен. 2, 2021

  Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business to PeptiDream

• Авг. 31, 2021

  Launch of Therapeutic Radiopharmaceutical Product, Lutathera^® Injection targeting neuroendocrine tumors in Japan  (FUJIFILM Toyama Chemical)